CA-PACKETFABRIC
9.2.2021 15:02:09 CET | Business Wire | Press release
PacketFabric , an innovator of on-demand connectivity for enterprise customers to the secure private internet, today announced a strategic partnership with Colt Technology Services, a leading provider of global high bandwidth connectivity solutions. This partnership sees Colt’s On Demand offering being directly integrated with PacketFabric’s Network-as-a-Service (NaaS) platform, initially enabling PacketFabric’s enterprise customers to benefit from real-time network connectivity to 100 key data center locations across Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210209005271/en/
PacketFabric’s global customer base can now create private, secure, low latency hybrid cloud and backbone connectivity in minutes, enabled via an API-based software defined interconnection with Colt. Colt’s On Demand platform is underpinned by the Colt IQ Network, which spans more than 29,000 on net buildings and 900 data centers globally, and will significantly increase the reach of PacketFabric’s advanced NaaS platform throughout Europe. Through this integration, PacketFabric’s enterprise customers will be able to benefit from a true SDN experience, which sees services being delivered in real-time via a portal, creating greater agility for the fast-paced business landscape of today.
“When we looked at our European expansion plans, it was clear that Colt was the right strategic partner for PacketFabric,” said Jezzibell Gilmore, PacketFabric Co-founder and Chief Commercial Officer. “Not only is Colt an innovator and pioneer in connectivity services, but they lead the telecom industry in diversity and inclusion. As a women-founded start-up, we are passionate how Colt CEO Keri Gilder has been a champion for women in the telecom and tech industry—so this partnership is personally meaningful for me and my co-founder Anna Claiborne.”
“Colt strives to transform the way the world works through the power of connectivity and this collaboration with PacketFabric will offer enterprise customers the agility and flexibility they need to take on the business challenges of today,” said Keri Gilder, CEO of Colt. “At Colt, we don’t just want to transform how networks are provisioned, we also believe in changing how this sector is viewed and the voices that are heard in it. I am passionate about championing women and I am proud to be partnering with a company created and led by women. I see this collaboration being just an example of how we are innovating and delivering the networks of tomorrow for customers globally.”
“Structure Research’s Global Data Center and Colocation Report reported that EU interconnection will continue to populate and expand, and the market will see significant expansion which bodes well for our partnership and joint enterprise customers,” said Anna Claiborne, PacketFabric Co-founder and SVP Product and Engineering.
The Colt IQ Network connects data centers across Europe, Asia and North America’s largest business hubs. PacketFabric’s Network-as-a-Service platform orchestrates and guarantees connectivity between colocation facilities, clouds, and offers private network interconnection. PacketFabric was recently awarded the “2020 Fierce Telecom Innovation Award for Cloud Services,” a “2020 Cool Vendor in Enhanced Internet Services and Cloud Connectivity” by Gartner and one of the “10 Hottest Networking Startups of 2020” by CRN.
About PacketFabric
PacketFabric redefines how the enterprise moves data by automating network connectivity services. Leveraging an entirely automated SDN-based network architecture and the latest in optical and packet switching technology, PacketFabric enables dynamic, real-time connectivity services between more than hundreds of premier colocation facilities across many global markets. The PacketFabric Network-as-a-Service (NaaS) platform delivers simple, cost-effective, and scalable network deployment via its advanced Application Program Interface (API) and web portal. PacketFabric was named the “2020 Fierce Telecom Innovation Award for Cloud Services,” one of the “10 Hottest Networking Startups of 2020” by CRN and a “2020 Cool Vendor in Enhanced Internet Services and Cloud Connectivity” by Gartner. PacketFabric investors include NantWorks and Digital Alpha Advisors. For more information, visit packetfabric.com .
About Colt
Colt strives to transform the way the world works through the power of connectivity, taking what’s always been in its DNA to enable customers’ success. The Colt IQ Network connects more than 900+ data centers and over 29,000 on net buildings across Europe, Asia and North America’s largest business hubs.
Colt understands today’s shifting connectivity requirements and provides agile, on-demand and secure high bandwidth networking and voice solutions to ensure enterprises can thrive. Customers include data-intensive organizations spanning over 210 cities in more than 30 countries. Colt is a recognized innovator and pioneer in Software Defined Networks (SDN) and Network Function Virtualization (NFV). Privately owned, Colt is one of the most financially sound companies in the sector, and because of this, it’s able to put its customers’ needs at its core. For more information, please visit www.colt.net .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005271/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom